BMS-986340
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for BMS-986340, covering 2025-12-22 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors [Phase 1, Phase 2]